Jiangsu Bioperfectus Technologies Co.Ltd(688399) issue a stock trading change announcement. The company's product New Coronavirus (SARS-CoV-2) antigen rapid test kit (self test) obtained the EU CE certification in December 23, 2021, and other related products were certified to supply the market. There are many ways to detect COVID-19 pneumonia, so the company's products are facing the market competition risk of similar products or other testing products. The impact on the company's future performance is uncertain. Please make careful decisions and pay attention to preventing investment risks.
© China Stock Market News